Status:
COMPLETED
CGM Use in Islet Transplant Recipients
Lead Sponsor:
University of Virginia
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Islet Transplantation
Type1 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A study assessing glucose variability in subjects with Type 1 Diabetes who have had islet transplant.
Detailed Description
Subjects who have an Islet Transplantation may have several outcomes including time when insulin is not required followed in some cases by additional insulin for glucose control as patients get furthe...
Eligibility Criteria
Inclusion
- Type 1 Diabetes Mellitus
- Recipient of Islet Transplantation
- Age 18 or older
- Females, not currently know to be pregnant
- Demonstration of proper mental status and cognition for the study
- Understanding and willingness to follow the protocol and informed consent form
- Access to the internet and willingness to upload data during the study, including use of personal laptop
Exclusion
- Pregnancy and intent to become pregnant during trial
- Use of acetaminophen (such as Tylenol)
- Current enrollment in another intervention clinical trial that affects glucose variability
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2019
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT03427931
Start Date
February 1 2018
End Date
July 11 2019
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia Center for Diabetes Technology
Charlottesville, Virginia, United States, 22903